XLV vs PPH
YTDYear to date
XLV wins+3.4 pts
Past year
PPH wins+1.1 pts
Fee
XLV winslower fee
Yield
PPH wins+0.4 pts
AUM
XLV43.4× more
2–2level
XLV and PPH · year-to-date · as of Nov 4, 2026 · AUM not scored
PPH vs S&P 500
1M$118.60 · −0.5% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M ▼3MYTD1Y3Y5YMAX
Total return−0.5%+10.2%+8.3%+17.0%+30.8%+69.4%+75.5%+371.4%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
VanEck PPH and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
PPH’s Holdings
TodayLLYEli Lilly &23.2%MRK12.5%NVO5.5%PFE5.1%MCK4.6%BMY4.5%TEVA4.5%COR4.3%GSK4.2%AZN3.8%NVS3.8%ABBV3.7%SNY3.4%HLN3.3%JNJ3.2%TAK2.9%ZTS2.7%VTRS1.5%JAZZAXSMCORT4 more
LLYEli Lilly &23.2%MRK12.5%NVO5.5%PFE5.1%MCK4.6%BMY4.5%TEVA4.5%COR4.3%GSK4.2%AZN3.8%NVS3.8%ABBV14 more
Drug Manufacturers - GeneralDrug Manufacturers - SpecialtyMedical - DistributionBiotechnologyMedical - Pharmaceuticals
VanEck PPH · 26 holdings · tile size = share of the fund · as of Nov 3, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.4% | +20.4% | $49.1B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.6% | +19.6% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +27.2% | +27.2% | $10.5B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +19.8% | +19.8% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +16.0% | +16.0% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −8.9% | −8.9% | $3.9B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.7% | +19.7% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +70.9% | +70.9% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.9% | +26.9% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.7% | +24.7% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.5% | +22.5% | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +33.8% | +33.8% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +21.8% | +21.8% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.0% | +17.0% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +24.5% | +24.5% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +35.0% | +35.0% | $525M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 4, 2026
PPH Payouts by Year
13YLatest payout, Oct 2026
$0.36
a share · every quarter
1.8% yield
1.8% yield
13 years added up
$17.62 a share
$17.62 a share
VanEck PPH · per-share distributions by ex-date · 2014–2026
PPH’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −0.3% | +20.4% | +29.7% | $49.1B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −0.1% | +19.6% | +28.1% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +1.9% | +27.2% | +38.1% | $10.5B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.4% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | −0.5% | +16.0% | +24.7% | $4.6B | |
| 6 | PPH | VanEck Pharmaceutical ETFThis fund | 0.36% | 1.8% | −0.5% | +17.0% | +30.8% | $1.1B |
#20 of 33 this year · #14 cheapest of 39 · sorted by assetsOpen the Sectors table →
PPH and its peer group · total return · as of Nov 4, 2026
Cards for This View
PPH’s Top 10 Holdings
Today72.2%of PPH sits in these 10
VanEck PPH · weight in the fund · as of Nov 3, 2026
PPH’s Holdings
TodayLLYEli Lilly &23.2%MRK12.5%NVO5.5%PFE5.1%MCK4.6%BMY4.5%TEVA4.5%COR4.3%GSK4.2%AZN3.8%NVS3.8%ABBV3.7%SNY3.4%HLN3.3%JNJ3.2%TAK2.9%ZTS2.7%VTRS1.5%JAZZAXSMCORT4 more
LLYEli Lilly &23.2%MRK12.5%NVO5.5%PFE5.1%MCK4.6%BMY4.5%TEVA4.5%COR4.3%GSK4.2%AZN3.8%NVS3.8%ABBV14 more
Drug Manufacturers - GeneralDrug Manufacturers - SpecialtyMedical - DistributionBiotechnologyMedical - Pharmaceuticals
VanEck PPH · 26 holdings · tile size = share of the fund · as of Nov 3, 2026
PPH vs Peer Average
YTDPPHAvsBPeer average
1D−0.5%+0.6%
1M+10.2%+4.0%
3M+8.3%+6.1%
YTD+17.0%+21.0%
1Y+30.8%+29.0%
3Y+69.4%+81.2%
5Y+75.5%+28.9%
4–3PPH wins
38 Health care peers · each row scaled to its leader